Related Experiment Video

Updated: Jun 15, 2026

Generation of Alginate Microspheres for Biomedical Applications
10:33

Generation of Alginate Microspheres for Biomedical Applications

Published on: August 12, 2012

[The experience of usage of alginate contain medication in complex therapy at children with GERD disease]

P L Shcherbakov, Iu F Lobanov, D S Fugol

    Eksperimental'Naia I Klinicheskaia Gastroenterologiia = Experimental & Clinical Gastroenterology
    |March 6, 2010
    PubMed

    Insights

    Alginate medications offer effective symptom relief for pediatric gastroesophageal reflux disease (GERD). This therapy addresses physiological challenges in children, improving outcomes and endoscopy results.

    Area of Science:

    • Pediatric Gastroenterology
    • Pharmacology
    • Medical Therapeutics

    Context:

    • Pediatric gastroesophageal reflux disease (GERD) presents unique therapeutic challenges due to physiological differences in children.
    • Many standard GERD medications have age restrictions, limiting treatment options for pediatric patients.
    • The metabolism and physiological responses to drugs differ significantly between children and adults.

    Purpose:

    • To evaluate the efficacy and safety of alginate-containing medications in the complex therapy of pediatric GERD.
    • To determine the impact of alginate therapy on common GERD symptoms in children.
    • To assess the role of alginate in improving endoscopic findings in pediatric GERD cases.

    Summary:

    • Alginate-containing medications were utilized in the complex treatment of pediatric GERD.
    • Therapy demonstrated rapid and effective relief from symptoms such as heartburn and eructation.
    • Positive changes in endoscopic evaluations were observed, indicating therapeutic benefit.

    Impact:

    • Alginate-based treatments provide a viable therapeutic option for pediatric GERD.
    • This approach can lead to improved symptom management and patient outcomes in children.
    • Further research into age-specific GERD pharmacotherapy is warranted.

    More Related Videos

    Culture of Small Colony Variant of Pseudomonas aeruginosa and Quantitation of its Alginate09:06

    Culture of Small Colony Variant of Pseudomonas aeruginosa and Quantitation of its Alginate

    Published on: February 22, 2020

    Related Concept Videos

    Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

    Gastroesophageal Reflux Disease II: Clinical Features and Management

    Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
    Clinical Manifestations
    GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
    Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids01:31

    Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids

    In the complex environment of the gastric lumen, excessive acid secretion can lead to the formation or worsening of ulcers within the delicate mucosal layer. Antacids, such as sodium bicarbonate and calcium carbonate, provide relief by neutralizing this acid, transforming it into harmless salt and water. This neutralization process raises the gastric pH from a highly acidic level of 1 to a more basic 3-4, reducing the acidity within the stomach.
    However, this neutralization reaction between...
    Peptic Ulcer Disease IV: Management01:26

    Peptic Ulcer Disease IV: Management

    Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
    The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
    Pharmacological management
    The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
    Barrett Esophagus-II: Clinical Manifestations and Management01:21

    Barrett Esophagus-II: Clinical Manifestations and Management

    Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
    To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
    Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents01:24

    Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

    In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
    In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

    Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...